Bellerophon Therapeutics Inc (NASDAQ:BLPH)
| 1.21 Delayed Data As of Jun 30 |  -0.20 / -13.99%Today’s Change | 0.67 Today|||52-Week Range 5.04 | -60.97% Year-to-Date |
Latest BLPH News | Press Releases
No recent news for Bellerophon Therapeutics Inc.
Today’s Trading
| Previous close | 1.43 |
| Today’s open | 1.43 |
| Day’s range | 1.05 - 1.50 |
| Volume | 181,918 |
| Average volume (3 months) | 57,372 |
| Market cap | $8.8M |
Data as of 4:01pm ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | +41.08% |
| Earnings growth (this year) | -27.85% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.41 |
Competitors
| ---- | ||
| IMRNImmuron Ltd | -0.26 | -10.81% |
| XBIOXenetic Biosciences ... | +0.05 | +7.17% |
| LOGCLogicBio Therapeutic... | -0.04 | -10.18% |
Data as of 4:00pm ET, 06/30/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
